152 related articles for article (PubMed ID: 35995509)
1. Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction.
Woods J; Pemberton SE; Largent AD; Chiang K; Liggitt D; Oukka M; Rawlings DJ; Jackson SW
J Immunol; 2022 Sep; 209(6):1033-1038. PubMed ID: 35995509
[TBL] [Abstract][Full Text] [Related]
2. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.
Warshauer JT; Belk JA; Chan AY; Wang J; Gupta AR; Shi Q; Skartsis N; Peng Y; Phipps JD; Acenas D; Smith JA; Tamaki SJ; Tang Q; Gardner JM; Satpathy AT; Anderson MS
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34115115
[TBL] [Abstract][Full Text] [Related]
3. Activation of gp130 signaling in T cells drives T
Baumgartner F; Bamopoulos SA; Faletti L; Hsiao HJ; Holz M; Gonzalez-Menendez I; Solé-Boldo L; Horne A; Gosavi S; Özerdem C; Singh N; Liebig S; Ramamoorthy S; Lehmann M; Demel U; Kühl AA; Wartewig T; Ruland J; Wunderlich FT; Schick M; Walther W; Rose-John S; Haas S; Quintanilla-Martinez L; Feske S; Ehl S; Glauben R; Keller U
Sci Signal; 2024 Feb; 17(824):eadc9662. PubMed ID: 38377177
[TBL] [Abstract][Full Text] [Related]
4. A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice.
Schmitt EG; Toth KA; Risma SI; Kolicheski A; Saucier N; Berríos RJF; Greenberg ZJ; Leiding JW; Bleesing JJ; Thatayatikom A; Schuettpelz LG; Edwards JR; Vogel TP; Cooper MA
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36136607
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.
Haapaniemi EM; Kaustio M; Rajala HL; van Adrichem AJ; Kainulainen L; Glumoff V; Doffinger R; Kuusanmäki H; Heiskanen-Kosma T; Trotta L; Chiang S; Kulmala P; Eldfors S; Katainen R; Siitonen S; Karjalainen-Lindsberg ML; Kovanen PE; Otonkoski T; Porkka K; Heiskanen K; Hänninen A; Bryceson YT; Uusitalo-Seppälä R; Saarela J; Seppänen M; Mustjoki S; Kere J
Blood; 2015 Jan; 125(4):639-48. PubMed ID: 25349174
[TBL] [Abstract][Full Text] [Related]
6. A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance.
Aqel SI; Yang X; Kraus EE; Song J; Farinas MF; Zhao EY; Pei W; Lovett-Racke AE; Racke MK; Li C; Yang Y
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33411696
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome.
Largent AD; Lambert K; Chiang K; Shumlak N; Liggitt D; Oukka M; Torgerson TR; Buckner JH; Allenspach EJ; Rawlings DJ; Jackson SW
Sci Transl Med; 2023 Jul; 15(703):eade7028. PubMed ID: 37406138
[TBL] [Abstract][Full Text] [Related]
8. A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice.
Toth KA; Schmitt EG; Kolicheski A; Greenberg ZJ; Levendosky E; Saucier N; Trammel K; Oikonomou V; Lionakis MS; Klechevsky E; Kim BS; Schuettpelz LG; Saligrama N; Cooper MA
J Exp Med; 2024 Aug; 221(8):. PubMed ID: 38861030
[TBL] [Abstract][Full Text] [Related]
9. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D
Masle-Farquhar E; Jackson KJL; Peters TJ; Al-Eryani G; Singh M; Payne KJ; Rao G; Avery DT; Apps G; Kingham J; Jara CJ; Skvortsova K; Swarbrick A; Ma CS; Suan D; Uzel G; Chua I; Leiding JW; Heiskanen K; Preece K; Kainulainen L; O'Sullivan M; Cooper MA; Seppänen MRJ; Mustjoki S; Brothers S; Vogel TP; Brink R; Tangye SG; Reed JH; Goodnow CC
Immunity; 2022 Dec; 55(12):2386-2404.e8. PubMed ID: 36446385
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and immunological analysis of the patient with autoimmunity due to germline STAT3 gain-of-function mutation].
Ding Y; Zhang Y; Wang YP; Zhao HY; Chen XM; Xue XH; Bai XM; An YF; Zhang ZY; Tang XM; Zhao XD
Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):30-36. PubMed ID: 28072956
[No Abstract] [Full Text] [Related]
11. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.
Harris TJ; Grosso JF; Yen HR; Xin H; Kortylewski M; Albesiano E; Hipkiss EL; Getnet D; Goldberg MV; Maris CH; Housseau F; Yu H; Pardoll DM; Drake CG
J Immunol; 2007 Oct; 179(7):4313-7. PubMed ID: 17878325
[TBL] [Abstract][Full Text] [Related]
12. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
13. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Milner JD; Vogel TP; Forbes L; Ma CA; Stray-Pedersen A; Niemela JE; Lyons JJ; Engelhardt KR; Zhang Y; Topcagic N; Roberson ED; Matthews H; Verbsky JW; Dasu T; Vargas-Hernandez A; Varghese N; McClain KL; Karam LB; Nahmod K; Makedonas G; Mace EM; Sorte HS; Perminow G; Rao VK; O'Connell MP; Price S; Su HC; Butrick M; McElwee J; Hughes JD; Willet J; Swan D; Xu Y; Santibanez-Koref M; Slowik V; Dinwiddie DL; Ciaccio CE; Saunders CJ; Septer S; Kingsmore SF; White AJ; Cant AJ; Hambleton S; Cooper MA
Blood; 2015 Jan; 125(4):591-9. PubMed ID: 25359994
[TBL] [Abstract][Full Text] [Related]
14. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
[TBL] [Abstract][Full Text] [Related]
15. An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation.
Saarimäki-Vire J; Balboa D; Russell MA; Saarikettu J; Kinnunen M; Keskitalo S; Malhi A; Valensisi C; Andrus C; Eurola S; Grym H; Ustinov J; Wartiovaara K; Hawkins RD; Silvennoinen O; Varjosalo M; Morgan NG; Otonkoski T
Cell Rep; 2017 Apr; 19(2):281-294. PubMed ID: 28402852
[TBL] [Abstract][Full Text] [Related]
16. Stat3 programs Th17-specific regulatory T cells to control GN.
Kluger MA; Luig M; Wegscheid C; Goerke B; Paust HJ; Brix SR; Yan I; Mittrücker HW; Hagl B; Renner ED; Tiegs G; Wiech T; Stahl RA; Panzer U; Steinmetz OM
J Am Soc Nephrol; 2014 Jun; 25(6):1291-302. PubMed ID: 24511136
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA NEAT1 inhibits Th17/CD4
Shui X; Chen S; Lin J; Kong J; Zhou C; Wu J
J Cell Physiol; 2019 Dec; 234(12):22477-22484. PubMed ID: 31119756
[TBL] [Abstract][Full Text] [Related]
18. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
19. IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.
Lee PW; Smith AJ; Yang Y; Selhorst AJ; Liu Y; Racke MK; Lovett-Racke AE
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878115
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]